機関投資家は シリコンラボの株で 異なった動きを見せました 市場資本額は415億ドルで 126.42ドルで取引されています Institutional investors made mixed moves in Silicon Laboratories stock, which trades at $126.42 with a $4.15B market cap.

第2四半期には,いくつかの機関投資家がSilicon Laboratories (SLAB) の株式を調整し,Lisanti Capital Growthが28,450株,Mackenzie Financialが234,924株,Pier 88 Investment Partnersが1,540株を購入しました. In the second quarter, several institutional investors adjusted their stakes in Silicon Laboratories (SLAB), with Lisanti Capital Growth buying 28,450 shares, Mackenzie Financial increasing its position by 234,924 shares, and Pier 88 Investment Partners selling 1,540 shares. ステファンズ・インベストメント・マネジメントは26,979株を追加し,セリティ・パートナーは755株を保有しました. Stephens Investment Management added 26,979 shares, while Cerity Partners boosted its holding by 755 shares. 株式は4.15億円の市場キャップで126.42ドルで取引され,マイナスのP/E比と12ヶ月の範囲で82.82ドルから160ドル. The stock, trading at $126.42 with a market cap of $4.15 billion, has a negative P/E ratio and a 12-month range of $82.82 to $160.00. 分析者は,各企業の評価は異なるが,合意の"Hold"評価と平均目標価格153.43ドルとで,混合した見通しを維持している. Analysts maintain a mixed outlook, with a consensus “Hold” rating and a $153.43 average target price, though individual firms vary in their assessments.